Tyme Technologies, Inc.
(NASDAQ : TYME)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Miscellaneous » Miscellaneous
symbolcompany%chnglast%shortavg$volume
XXII22nd Century Group, Inc.
10.65%2.393.8%$4.72m
TACODel Taco Restaurants, Inc.
7.18%13.888.5%$4.14m
LINDLindblad Expeditions Holdings Inc
-1.08%12.811.4%$2.32m
ABILAbility, Inc.
10.77%5.045.8%$2.15m
RILYB. Riley Financial, Inc.
6.54%22.001.2%$1.49m
PMEPingtan Marine Enterprise Ltd.
0.37%2.700.9%$0.34m
CCCLChina Ceramics Co. Ltd.
4.55%1.612.6%$0.09m
SGOCSGOCO Group Ltd.
0.82%1.230.1%$0.07m
RMGNRMG Networks Holding Corporation
-0.41%1.220.2%$0.06m
WINSWins Finance Holdings, Inc.
8.25%89.850.4%$0.03m
PANLPangaea Logistics Solutions Ltd.
-0.32%3.100.0%$0.03m
BHACUBarington/Hilco Acquisition Corp Units Cons of 1 Sh + 1 Rt + 1 Wt
33.72%18.600.0%$0.00m

Company Profile

Tyme Technologies, Inc. operates as a clinical-stage biopharmaceutical company focused on development and commercialization of highly targeted cancer therapeutics with a broad range of oncology indications. Its clinical program, SM-88 is a novel combination therapy based on dysfunctional metyrosine derivatives and has shown complete or partial imaging responses in 15 different cancer subtypes, including solid tumors, sarcomas, gliomas and hematological malignancies, without demonstrating drug-related severe adverse events. The company was founded on November 22, 2011 and is headquartered in New York, NY.